Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 24 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Personalized NK Cell Therapy in CBT
NCT02727803
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02115295
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Crisis, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03326921
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03779854
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
Recruiting
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
NCT04797767
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +26 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03683433
- Conditions
- Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Bone Marrow Diseases, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02220985
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
- Locations
-
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02397720
- Conditions
- Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00719888
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02135874
- Conditions
- Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01858740
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +41 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT03096782
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01951885
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +41 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT03267186
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +23 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
NCT02728050
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +18 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00796068
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +25 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Oregon Health and Science University Portland, Oregon, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02529813
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, +28 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +22 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- University of Colorado Denver, Colorado, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT02044796
- Conditions
- Acute Biphenotypic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01804101
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States